Modelling Approaches Should Be Justified in Economic Analyses

被引：0
|
作者：
不详
机构：
来源：
PHARMACEUTICAL MEDICINE | 2019年 / 33卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：538 / 538
页数：1
相关论文
共 50 条
  • [1] Basing economic analyses on the Framingham heart study risk equations: Is it still justified?
    Caro, J
    Klittich, WS
    Ford, I
    Norrie, J
    CIRCULATION, 1998, 98 (17) : 812 - 812
  • [2] Should clinical trials with concurrent economic analyses be blinded?
    Freemantle, N
    Drummond, M
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (01): : 63 - 64
  • [3] HEALTH ECONOMIC MODELLING APPROACHES IN CELL AND GENE THERAPIES
    Mumford, A.
    Ringger, D.
    Lewis, H.
    VALUE IN HEALTH, 2022, 25 (07) : S509 - S509
  • [4] When is economic inequality justified?
    Prasad, Ajnesh
    BUSINESS HORIZONS, 2018, 61 (06) : 855 - 862
  • [5] Computational modelling approaches to meditation research: why should we care?
    van Vugt, Marieke
    Moye, Amir
    Sivakumar, Swagath
    CURRENT OPINION IN PSYCHOLOGY, 2019, 28 : 49 - 53
  • [6] THE USE OF NNT MODELLING TO IMPROVE THE CLINICAL RELEVANCE OF ECONOMIC ANALYSES
    Weston, G.
    Robinson, E.
    Hughes, R.
    Hirst, A.
    VALUE IN HEALTH, 2023, 26 (06) : S49 - S49
  • [7] Legal Proof Should Be Justified Belief of Guilt
    Guenther, Mario
    LEGAL THEORY, 2024, 30 (03) : 129 - 141
  • [8] Toward global modelling approaches for dynamic analyses of rotating assemblies of turbomachines
    Chatelet, E
    D'Ambrosio, F
    Jacquet-Richardet, G
    JOURNAL OF SOUND AND VIBRATION, 2005, 282 (1-2) : 163 - 178
  • [9] FEM Modelling Approaches of Bolt Connections for the Dynamic Analyses of an Automotive Engine
    Giannella, Venanzio
    Sepe, Raffaele
    Citarella, Roberto
    Armentani, Enrico
    APPLIED SCIENCES-BASEL, 2021, 11 (10):
  • [10] Cost-Effectiveness Analyses in Multiple Sclerosis: A Review of Modelling Approaches
    Guo, Shien
    Pelligra, Christopher
    Thibault, Catherine Saint-Laurent
    Hernandez, Luis
    Kansal, Anuraag
    PHARMACOECONOMICS, 2014, 32 (06) : 559 - 572
12345